We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
Cap. Flow
+$28.6B
Cap. Flow %
52.81%
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782

Sector Composition

Rank Sector Weight
1 Technology 17.77%
2 Healthcare 17.47%
3 Financials 15.58%
4 Consumer Discretionary 12.3%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWBI icon
3276
Smith & Wesson
SWBI
$662M
$127K ﹤0.01%
+7,128
New +$147K
VVNT
3277
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
$127K ﹤0.01%
+13,000
New +$127K
FXE icon
3278
Invesco CurrencyShares Euro Currency Trust
FXE
$342M
$126K ﹤0.01%
1,187
-1,903
-62% -$203K
ANIX icon
3279
Anixa Biosciences
ANIX
$120M
$125K ﹤0.01%
41,973
BIOX icon
3280
Bioceres Crop Solutions
BIOX
$20.6M
$125K ﹤0.01%
+8,754
New +$121K
PAYS icon
3281
Paysign
PAYS
$511M
$125K ﹤0.01%
+78,298
New +$168K
LRMR icon
3282
Larimar Therapeutics
LRMR
$394M
$124K ﹤0.01%
11,392
-15,195
-57% -$169K
RCL icon
3283
CALL
Royal Caribbean
RCL
$86.1B
$123K ﹤0.01%
+1,600
New +$130K
GHG
3284
GreenTree Hospitality
GHG
$115M
$122K ﹤0.01%
15,347
-217,705
-93% -$1.8M
EMKR
3285
DELISTED
Emcore Corp
EMKR
$122K ﹤0.01%
1,751
-6,205
-78% -$457K
IGV icon
3286
CALL
iShares Expanded Tech-Software Sector ETF
IGV
$12.4B
$120K ﹤0.01%
1,500
MGIC
3287
DELISTED
Magic Software Enterprises
MGIC
$120K ﹤0.01%
+5,761
New +$125K
SUZ icon
3288
Suzano
SUZ
$10.4B
$120K ﹤0.01%
+11,189
New +$108K
TK icon
3289
Teekay
TK
$979M
$120K ﹤0.01%
+38,459
New +$133K
TRON
3290
DELISTED
Corner Growth Acquisition Corp. 2 Class A Ordinary Share
TRON
$120K ﹤0.01%
12,171
VCEL icon
3291
Vericel Corp
VCEL
$2.37B
$119K ﹤0.01%
+3,031
New +$133K
VSXY
3292
Victoria's Secret
VSXY
$7.09B
$119K ﹤0.01%
+2,142
New +$112K
IHE icon
3293
iShares US Pharmaceuticals ETF
IHE
$1.5B
$118K ﹤0.01%
+1,776
New +$113K
TALO icon
3294
Talos Energy
TALO
$2.28B
$118K ﹤0.01%
+12,088
New +$138K
CTKB icon
3295
Cytek Biosciences
CTKB
$585M
$117K ﹤0.01%
+7,160
New +$150K
MRKR icon
3296
Marker Therapeutics
MRKR
$20M
$117K ﹤0.01%
12,348
-4,723
-28% -$62.7K
HIPO.WS
3297
CALL
DELISTED
Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share
HIPO.WS
$117K ﹤0.01%
+41,377
New +$28.7K
CPRI icon
3298
CALL
Capri Holdings
CPRI
$1.88B
$116K ﹤0.01%
1,800
RMCO icon
3299
Royalty Management
RMCO
$35.5M
$116K ﹤0.01%
11,524
EXTN
3300
DELISTED
Exterran Corporation
EXTN
$116K ﹤0.01%
+38,905
New +$154K

Similar funds

Marshall Wace's Q4 2021 Portfolio in Review

As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.

  • Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
  • Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
  • Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
  • Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
  • Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
  • Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
  • Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.